Skip to content A Place for Diligent Pharma Solutions
Home Founder
Portfolio Evaluation and ManagementEvaluation, forecasting and three-scenario business cases Business Development FacilitationFrom partner scouting to alliance management PULSE – US Generic ApprovalsA monthly report on US FDA approvals

Inside Portfolio Evaluation

What we doHow it helps youServices we offerOur processSample business caseRecent projectsRequest a demo
Licensing Opportunities Company Updates Enquiries & Contact
A Place for Diligent Pharma Solutions

Diligent pharma solutions for a changing global market

Portfolio evaluation and business development for formulations and APIs, across regulated and emerging markets. We enable you to make informed decisions with confidence.

Send an enquiryView licensing opportunities
United KingdomEuropeUnited StatesCanadaLatin America Hyderabad, India

30+ years of pharma experience. 1000+ products evaluated. Multiple licensing collaborations facilitated.Multiple CMO, CRO and CDMO relationships.

  • Trusted for Evaluation
  • Defined by Expertise
  • Driven by Excellence
EuropeUnited KingdomLatin AmericaUnited StatesCanadaEuropeUnited KingdomLatin AmericaUnited StatesCanada

Our Core Services

From portfolio evaluation and market intelligence to business development and licensing, we provide focused expertise to support informed decisions and strategic partnerships.

  1. Evaluate Portfolio Evaluation and Management Detailed evaluation, forecasting and three-scenario business cases, so you know which products deserve investment before you commit.
  2. Facilitate Business Development Partnerships From partner scouting to alliance management: in-licensing, supply, distribution, technology transfer and manufacturing partnerships.
  3. Monitor PULSE A monthly US approvals report that enables informed, proactive portfolio decisions.
Pavani JSL, Founder of Pavani Consultancy Services

Pavani JSL, Founder

With over 30 years of pharmaceutical expertise, Pavani JSL is a visionary strategist enabling companies toward sustainable global growth.

Pavani leads Pavani Consultancy Services, working directly with C-suite executives to optimise pharmaceutical portfolios, identify market opportunities and facilitate strategic partnerships across the US, EU and emerging markets. Her extensive product and portfolio experience, combined with a strong global industry network, enables structured strategies grounded in commercial insight and practical execution.

Career with Glaxo, Dr. Reddy’s, Aurobindo, Mylan and Hetero

Read her profile

Why partner with us

Experience, expertise and excellence

Deep industry experience
30+ years in portfolio and BD facilitation.
Proven track record
1000+ evaluations, multiple deals.
Functional expertise
One-stop expertise across Formulations and APIs.
Strong global network
EU-GMP and USFDA CDMOs, CMOs and CROs.
Confidential and agile
Fast response, proactive follow-up.
Pavani Consultancy Services – 7th Anniversary, Est. 2019

Est. 2019

Seven years of diligent pharma solutions

Thank you to our partners and clients for seven years of trust.

Built on trusted experiences

Designations are as at the time each testimonial was given.

A place for diligent pharma solutions

Pavani Consultancy Services, established in Hyderabad in 2019, is a pharmaceutical portfolio and business development consultancy. We evaluate products across the US, EU and emerging markets. We facilitate licensing and strategic partnerships between pharmaceutical companies, CDMOs, CMOs and CROs. PCS also publishes PULSE, a monthly report tracking US FDA approvals.

  • Trusted for Evaluation
  • Defined by Expertise
  • Driven by Excellence
Pavani JSL

Pavani JSL

Founder, Pavani Consultancy Services

Connect on LinkedIn Company on LinkedIn

Meet our founder

Pavani JSL is an accomplished pharmaceutical industry expert and consultant with over three decades of experience in strategic leadership and global business development.

Founder and Principal Consultant
Leads Pavani Consultancy Services, delivering strategic advisory in pharmaceutical portfolio management, market intelligence and business development to support informed decision-making and sustainable growth.
Core competencies
Portfolio strategy, Global in-licensing and out-licensing, market intelligence, strategic business development, and long-term growth execution.
Impact
Enabling pharmaceutical manufacturers and life sciences companies to optimise product portfolios, identify global market opportunities, prioritise investments and establish strategic partnerships.

When you partner with Pavani Consultancy Services, you gain direct access to an experienced pharmaceutical consultant with a Master’s in Business Administration and an International Business programme from IIM Calcutta, backed by extensive experience evaluating hundreds of products across the US, EU and ROW markets.

Our experience, structured approach and global perspective combine rigorous evaluation methodologies, strategic portfolio insights, KOL-driven marketing strategies and a strong network of global industry connections to support informed leadership decisions and sustainable business growth.

ExperienceApproachGlobal Perspective

Milestone achievements

1000+

Products evaluated

For active development across the US, EU and ROW markets.

5year

Strategic portfolio roadmaps

Designed for global portfolios.

Multiple

Companies, business development

Collaborations facilitated and major licensing deals closed in respiratory, aesthetic and gynaecological therapies.

Where it all comes together

A career spanning five companies, bringing together expertise in pharmaceutical portfolio management and business development at Pavani Consultancy Services.
Select a company to explore her role and experience.

Services/Portfolio Evaluation and Management

Know which products deserve your investment before you commit to them

Request a demo

1000+ products evaluated across varied dosage forms and therapeutic areas, guiding launches in the US, EU, SE Asia and LATAM markets.

On this page

What we doHow it helps youServices we offerA. Detailed Portfolio EvaluationB. Forecasting for Regulated MarketsC. Business Case for Regulated MarketsOur processSample business caseRecent projectsRequest a demo

What We Do

We enable pharmaceutical companies to build commercially viable product portfolios across the US, EU and emerging markets.

Working directly with C-suite leaders, we evaluate opportunities at the product, market, dosage form and therapy levels. Our recommendations are supported by market intelligence, commercial forecasting and robust business cases to enable informed investment decisions.

How an Assessment Helps You

Make Go / No-Go Decisions Before Investing
Evaluate each product's commercial potential before committing development budgets.
Allocate Budgets to the Right Products
Prioritise opportunities based on commercial attractiveness, directing limited R&D resources towards products with stronger return potential.
Plan Around Market Entry Windows
Map patent and exclusivity timelines, earliest filing opportunities and projected launch dates to identify viable entry windows.
Understand the Competitive Landscape Early
Assess existing DMFs, CEPs, ANDAs and Marketing Authorisations to understand competition and anticipate market crowding at the time of entry.
Evaluate API and Formulation Opportunities Separately
Assess each opportunity independently, recognising that API and formulation opportunities may have different commercial potential and investment priorities.
Forecast Future Market Potential
Project market volumes and values, incorporating generic entry timelines and anticipated price erosion to estimate market conditions at launch.
Build Business Cases for Investment Decisions
Develop three-scenario revenue and margin projections to support internal investment approvals and partner discussions.

Three Services, Curated to Your Needs.

Engage any service independently or combine them to suit your objectives. Each engagement is tailored to your product portfolio, target markets and business priorities.

A

Detailed Portfolio Evaluation

Carried out at product, market, dosage form or therapy level.

  • Product synopsis
  • Preliminary IP assessment
  • Mechanism of action
  • Comparative molecule assessment with clinical trials
  • Bio guidance for the US and EU
  • Competitive scenario: API (DMFs, CEPs) and formulation approvals (ANDAs, MAs)
  • Market assessment in volumes and values

How an evaluation flows

From executive summary to strategic recommendation, explore the key sections of a typical evaluation. Click any section to see how the analysis is presented. Examples are illustrative only and contain no actual figures.

Illustrative example

B

Forecasting for Regulated Markets

Forward view of the market you would be entering.

  • Volume and value forecasts by country
  • Generic entry timing and price erosion built in
  • API consumption derived from formulation volumes
  • Assumptions stated so they can be challenged and updated
Market forecast with generic entryIllustrative. Shape of a typical forecast: volume grows while value falls once generics enter.
C

Business Case for Regulated Markets

Your own revenue and margin picture, under three scenarios.

PessimisticRealisticOptimistic
  • Market share, volume, revenue and gross margin per scenario
  • Separate cases for formulations and API
  • Country-by-country view and launch sequence
  • A clear recommendation: proceed, proceed with caution, or drop

Recent Portfolio Evaluations

Technologies

  • Proprietary technology fitment
  • Nanoparticles
  • Extrusion
  • Spheronization
  • Transdermal patches

Product types

  • ODTs
  • ODFs
  • Oral solid dosages
  • Suppositories
  • Liquids
  • Injections
  • 505(b)(2) opportunities

Therapy areas

  • Oncology (unexpired patents)
  • ADHD
  • Ophthalmics
  • Topicals
  • Hemostatic agents
  • Wound management

Evaluated across the US, EU, SE Asia and LATAM markets, along with numerous individual product-level evaluations.

Walk through a sample evaluation

We would be happy to walk you through a sample evaluation, forecast and business case.

Request a demo

Services/Business Development Facilitation

From scouting to alliance management

We bridge the gap between CDMOs, CMOs, CROs and global partners through strategic alliances, enabling licensing, tech transfer and co-development. End-to-end handholding with global reach and a US and EU focus.

Explore licensing opportunitiesStart a BD enquiry

From lead to deal, and beyond

  1. Scouting
  2. Interest check
  3. CDA
  4. Volume and pricing fit
  5. Term sheet
  6. Negotiations
  7. Draft agreement
  8. Agreement sign-off
  9. Alliance management

Business models we facilitate

In-licensing
A partner’s molecule or technology into your portfolio.
Supply agreements
Fixed-term commercial supply of product.
Distribution
Market access via a local partner.
Technology transfer
Process, dossier and know-how transfer.
Manufacturing (CMO / CDMO)
Contract manufacturing partnerships.
Hybrid / multi-component
Combined licensing, supply and tech transfer.

Where we have worked

Collaborations facilitated and opportunities advanced to final-stage negotiation, by market. Select a market to see recent projects there.

Collaborations facilitatedAdvanced to final stage

Collaborations facilitated

Let’s structure your next deal

Start a BD enquirySee current opportunities
PULSE – Product approvals Updates & Landscape Summary Enabler

Services/PULSE

US FDA approvals, enabling decision making

PULSE is a decision enabler. Every month it turns US FDA approvals into a landscape report that tells you where competition is thin, where API supply is tight and what is about to launch, so your product choices rest on current evidence.

PULSE is a subscription report. It is more than an Excel file: subscribers get interactive data views alongside the workbook.

Request a demo

Interactive data views, tailored to your specific requirements

What you want.
Way you want.
When you want.

  • Which product received approval
  • Who received approval
  • How many players received approval so far
  • How many DMF holders are active

Who PULSE is for

Portfolio managers, BD and in-licensing teams, API sourcing teams, regulatory and ANDA strategy, and CDMOs planning capacity.

Inside The Report

A glimpse into the visual intelligence behind our reports. Explore selected dashboard layouts, with the full report offering an extensive range of dashboards, graphical analyses and interactive features. All examples are illustrative.

Sample layout

What you receive, and the decisions it enables

Each dashboard answers a question your portfolio and BD teams have to decide on.

Every subscriber receives

A monthly report. The full PULSE workbook every month, turning US FDA approvals into a landscape you can act on.

  1. You receive

    Competition and API supply watch

    Molecules with few active generics or few DMF holders, so you can see where competition is thin and API supply is tight.

    So you can decide

    Which molecules to add to the pipeline

    PULSE shows approvals with five or fewer active generics, and first and sole generics.

  2. You receive

    Launch watch

    Tentative approvals tracked by molecule, so you know which generics are about to reach the market.

    So you can decide

    Whether to continue or drop a product in development

    PULSE shows how many competitors are already approved and how fast the field is filling.

  3. You receive

    Interactive data views

    Filter by month, company, dosage form, route and pathway to build the view you need.

    So you can decide

    Which dosage forms and capabilities to invest in

    PULSE shows the trend by dosage form, route and injectables.

  4. You receive

    Insights and strategic implications

    A summary of what changed and what it means for your portfolio and partnering choices.

    So you can decide

    Which companies to benchmark and what you are up against

    PULSE presents US FDA approvals company-wise, consolidating related groups to help you benchmark peers, track their approval activity and understand the competitive landscape.

See PULSE for yourself

Request a demo

Company Updates

Our projects, milestones and updates—all in one place.

Our LinkedIn feed is provided by Elfsight, a third-party service that may set its own cookies. It loads only with your permission.

Open LinkedIn instead
Archive

Older posts are kept here so the main feed stays focused on what is current.

Browse older posts on LinkedIn

Products available for licensing

Our current list of products available for licensing and partnership, from US FDA-approved and EU-GMP approved facilities.

Facility
Dosage form

Select multiple products as needed and submit them together as a single enquiry.

Looking for a Specific Product?

Email us at pavanijsl@pavanics.com with your product and target markets. We will explore potential sourcing opportunities to meet your requirements.

Availability notice. The products listed are indicative, and not every product requested will be available at the time of your enquiry. Sales and negotiations take place on a live basis, so a product may be closed for specific countries. Once your enquiry is received, we will check availability for your markets and respond accordingly.

No products selected

Let’s structure your next deal

Email
pavanijsl@pavanics.com
Phone
+91 93947 12398
LinkedIn
Pavani JSL – Pavani Consultancy Services
Office
#214, 2nd Floor, Pranava Vaishnoi Business Park, Kothaguda, Hyderabad – 500084, Telangana, India
Select the areas you wish to discuss

Select the services you would like to discuss. Adding a message is optional.

Your details

By sending this form you agree to us using your details to reply to you. See our Privacy & Cookies page.

Thank you

Privacy & Cookies

Last updated: October 2026

Who we are

This website is operated by Pavani Consultancy Services, Hyderabad, Telangana, India. For any privacy question, write to pavanijsl@pavanics.com.

What we collect

Only what you type into our enquiry, demo and licensing forms: name, company, email, phone (optional) and message. The details are emailed to our team and used to reply to you and to keep a business record of the enquiry.

Spam protection

Our forms use Cloudflare Turnstile to confirm that a real person is sending the enquiry. Turnstile receives technical information from your browser for this purpose only.

Your rights

You may ask us to access, correct or delete the personal data we hold about you, or to stop contacting you, by emailing us. We handle requests under applicable data protection law, including India’s Digital Personal Data Protection Act, 2023 and, for visitors in the EU or UK, the GDPR.

Cookies and similar storage

Name or providerPurposeTypeDuration
pcs_consent (this site)Remembers your cookie choiceEssentialUntil you clear your browser data or change your choice
Cloudflare TurnstileSpam protection on formsEssential (security)Session
ElfsightShows our LinkedIn posts on the Company Updates page. May set its own cookiesThird-party content, only with your permissionSet by Elfsight

We do not use advertising or analytics cookies. You can change your choice at any time using Cookie settings in the footer. Our fonts are served from this website, so no font requests are made to third parties.

Links to LinkedIn and other sites are governed by their own policies.

About us

OverviewFounderCompany Updates

Business

Portfolio Evaluation and ManagementBusiness Development FacilitationPULSE

Quick links

Licensing OpportunitiesEnquiries & ContactPrivacy & Cookies

Headquarters

Hyderabad, Telangana, India

#214, 2nd Floor, Pranava Vaishnoi Business Park, Kothaguda – 500084pavanijsl@pavanics.com+91 93947 12398
Copyright © 2026 Pavani Consultancy Services. All rights reserved.Privacy & Cookies

Cookies and your privacy

We use essential storage to remember your choices and keep our forms secure. With your permission we also load third-party content, such as our LinkedIn feed (provided by Elfsight), which may set its own cookies. See Privacy & Cookies.